Physician Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$338K Buy
646
+12
+2% +$6.14K 0.04% 153
2026
Q2
$315K Sell
634
-10
-2% -$4.43K 0.04% 152
2026
Q1
$288K Sell
644
-68
-10% -$31.7K 0.04% 153
2025
Q4
$323K Buy
712
+14
+2% +$6.03K 0.04% 135
2025
Q3
$273K Buy
698
+157
+29% +$65.6K 0.04% 152
2025
Q2
$241K Buy
541
+3
+0.6% +$1.38K 0.04% 159
2025
Q1
$261K Buy
538
+40
+8% +$18.6K 0.04% 149
2024
Q4
$201K Sell
498
-32
-6% -$14.8K 0.03% 182
2024
Q3
$257K Sell
530
-27
-5% -$13K 0.05% 154
2024
Q2
$272K Buy
+557
New +$242K 0.05% 136
2022
Q1
– Sell
-929
Closed -$206K – 169
2021
Q4
$206K Buy
+929
New +$181K 0.05% 155
2021
Q2
– Sell
-967
Closed -$208K – 156
2021
Q1
$208K Buy
+967
New +$212K 0.07% 137

Other funds holding VRTX

Physician Wealth Advisors's VRTX Position: Q3 2026 in Review

Physician Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q3 2026, buying an estimated $6.14K and bringing the position to 646 shares worth $338K. The position accounts for 0.04% of the portfolio, ranked #153.

Physician Wealth Advisors first reported a position in VRTX in Q1 2021 and has held it in 12 quarters since. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Physician Wealth Advisors held 646 shares of Vertex Pharmaceuticals worth $338K as of Q3 2026.
  • Physician Wealth Advisors bought 12 Vertex Pharmaceuticals shares in Q3 2026, an estimated $6.14K.
  • Vertex Pharmaceuticals made up 0.04% of Physician Wealth Advisors's portfolio in Q3 2026, its #153 holding.
  • Physician Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 12 quarters since.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.